Treatment resistant impetigo herpetiformis treated with infliximab

Abstract

Impetigo herpetiformis is a rare disease of pregnancy with the onset being in the second half of pregnancy and resolution after delivery. It is associated with a high rate of perinatal mortality and fetal abnormalities. Clinical and histological features of the disease are consistent with pustuler psoriasis. We reported a case of 25‐year‐old female gravida 1 para 0, who responded poorly to consecutively treatments with systemic steroids, cyclosporine, intravenous immunoglobulin, and acitretin. Good response was obtained with adding infliximab to the treatment.

This article is protected by copyright. All rights reserved.

http://bit.ly/2FUQsng